Shared Services 2018 Q1 Quarterly Newsletter

SAFE-BIOPHARMA® ASSOCIATION MERGES WITH H-ISAC

 

ADDRESSING THE PROBLEM OF WEAK IDENTITY TRUST

The pharmaceutical industry developed the SAFE-BioPharma® digital signature and identity standards to address important challenges faced by healthcare companies every day:  privacy, security, efficiency, and regulatory compliance. The merger  between H-ISAC and SAFE-BioPharma Association will help H-ISAC members address important challenges around community-wide identity trust.

Continue with newsletter:

CYBERFIT Newsletter 2018 Q1